
Taiwanese startup HanchorBio signs $200 M deal to expand immuno-oncology reach
Taiwanese startup HanchorBio signs $200 M deal to expand immuno-oncology reach July 1, 2025 | Tuesday | News A critical milestone for HanchorBio's biopharmaceutical innovation HanchorBio Inc., a Taiwan-based biotechnology startup developing innovative …